Showing 1 - 10 of 580
Persistent link: https://www.econbiz.de/10010336462
Persistent link: https://www.econbiz.de/10010336465
Persistent link: https://www.econbiz.de/10009656216
For decades, the US public and private sectors have committed substantial resources towards cancer research, but the societal payoff has not been well-understood. We quantify the value of recent gains in cancer survival, and analyze the distribution of value among various stakeholders. Between...
Persistent link: https://www.econbiz.de/10012463075
For decades, the US public and private sectors have committed substantial resources towards cancer research, but the societal payoff has not been well-understood. We quantify the value of recent gains in cancer survival, and analyze the distribution of value among various stakeholders. Between...
Persistent link: https://www.econbiz.de/10012940684
Persistent link: https://www.econbiz.de/10009303017
Medical care at the end of life, estimated to contribute up to a quarter of US health care spending, often encounters skepticism from payers and policy makers who question its high cost and often minimal health benefits. It seems generally agreed upon that medical resources are being wasted on...
Persistent link: https://www.econbiz.de/10014198525
Medical care at the end of life, estimated to contribute up to a quarter of US health care spending, often encounters skepticism from payers and policy makers who question its high cost and often minimal health benefits. However, though many observers have claimed that such spending is often...
Persistent link: https://www.econbiz.de/10013148867
Persistent link: https://www.econbiz.de/10003923781
Persistent link: https://www.econbiz.de/10003926717